The essence of the pharmaceutical to 10 to 2-5 shares or lower than expected today to stop

NetEase Financial January 7, the essence of the pharmaceutical evening release of the announcement, the company's stock price in January 4, 2011, 5th, 6th three consecutive trading days closed price deviation value accumulated more than 20%, has constituted a stock trading abnormal fluctuations, 7th open for one hour. The essence of pharmaceutical said that, after verification, did not find that the recent media reports may or has a large impact on the company's stock trading prices have not disclosed significant information; the production and operation of the company is normal, the internal and external business environment has not undergone significant changes, and the company and the controlling shareholder, the actual controller does not exist should not disclose the major issues,　　There is no significant issue at the planning stage. The essence of pharmaceuticals also indicated that the annual audit of the company was in progress, and that the net profit growth rate had increased by 20% to 40% per cent, and that the profit allocation programme for 2010 had not yet been decided, but that the allocation programme initially prepared by the board of directors had been increased by 2-5 for each 10-share,　　The specific profit distribution plan still needs to be decided by the Board of Directors and approved by the shareholders ' meeting. Today close, the essence of pharmaceutical reported 42.9 yuan, tumbled 6.54%, the afternoon soon sealed down to stop, volume amplification, turnover rate of more than 20%.